Introduction
Maintenance of a luminal acidic environment in the exocytic and endocytic pathways is required at various stages in the processing and sorting of vesicle contents for a variety of signaling molecules, secretory and surface proteins, and ligand-receptor complexes Weisz, 2003) . The secretory granules have a luminal pH of 5.0-5.5 (Arvan and Castle, 1986; Orci et al., 1986; Urbe et al., 1997) , and their acidification has important roles in the condensation and maturation of their contents (Hutton, 1994) . The electrochemical proton gradient across the membrane provides the energy for accumulation of neurotransmitters into synaptic vesicles (Moriyama and Futai, 1990; Nelson, 1993) . Many growth factors are produced as latent inactive forms within the endoplasmic reticulum and undergo several modifications during travel through the Golgi apparatus, before being converted to mature active forms within the secretory vesicles. For instance, processing of insulin from proinsulin initiates in clathrin-coated secretory vesicles (Orci et al., 1987) by the activities of two enzymes, PC2 and PC3. Because PC3 shows a strict pH dependence (Orci et al., 1994; Smeekens et al., 1992) , the acidification inside the secretory vesicles has fundamental importance for maintenance of whole-body homeostasis. It has been suggested for decades that the proton gradients might be involved in the fusion of secretory vesicles to the target membrane (Al-Awqati, 1986; Burgess and Kelly, 1987) . Barg et al. showed that the acidic pH might regulate priming of the granules for secretion, a process involving pairing of SNARE proteins on the vesicles and target membranes to establish fusion competence (Barg et al., 2001) .
Recently, several lines of evidence indicated that the membrane fusion events are regulated by a proton-pumping vacuolar-type ATPase (V-ATPase), which is the key enzyme acidifying a wide variety of intracellular compartments and some extracellular milieus. V-ATPase is a multi-subunit complex that comprises two major functional sectors known as V 1 and V O . The V 1 sector is involved in ATP hydrolysis and consists of eight subunits (A, B, C, D, E, F, G and H) (for reviews, see Futai et al., 2000; Nelson and Harvey, 1999; Nishi and Forgac, 2002; Sun-Wada et al., 2003) . The V O sector consists of up to 6 subunits (a, c, cЈ, cЉ d and e) and forms a proton pathway (Anraku, 1996) . In yeast vacuolar fusion, this membrane-intrinsic sector has been demonstrated to be an essential component (Peters et al., 2001) . Interaction between the SNARE complex and the V O sector has been shown in Torpedo nerve terminals (Morel et al., 2003) . Most recently, Hiesinger et al. demonstrated genetically and electrophysiologically that the Drosophila V-ATPase a subunit has a regulatory function in a late step of synaptic vesicle exocytosis (Hiesinger et al., 2005) . Mutant Caenorhabditis elegans with a mutation at V O subunit e (fus-1) or C. elegans with impaired V-ATPase function induced by RNA interference (RNAi) exhibit hyperactive cell-cell fusion (Kontani et al., 2005) . These results are highly indicative that the V-ATPase is directly or indirectly involved in dynamic membrane interaction, including vesicle transport or cell-cell Vacuolar-type H + -ATPase (V-ATPase) is a multi-subunit enzyme that has important roles in the acidification of a variety of intracellular compartments and some extracellular milieus. Four isoforms for the membraneintrinsic subunit (subunit a) of the V-ATPase have been identified in mammals, and they confer distinct cellular localizations and activities on the proton pump. We found that V-ATPase with the a3 isoform is highly expressed in pancreatic islets, and is localized to membranes of insulincontaining secretory granules in ␤ ␤-cells. oc/oc mice, which have a null mutation at the a3 locus, exhibited a reduced level of insulin in the blood, even with high glucose administration. However, islet lysates contained mature insulin, and the ratio of the amount of insulin to proinsulin in oc/oc islets was similar to that of wild-type islets, indicating that processing of insulin was normal even in the absence of the a3 function. The insulin contents of oc/oc islets were reduced slightly, but this was not significant enough to explain the reduced levels of the blood insulin. The secretion of insulin from isolated islets in response to glucose or depolarizing stimulation was impaired. These results suggest that the a3 isoform of V-ATPase has a regulatory function in the exocytosis of insulin secretion.
fusion. However, the precise molecular mechanism as to how V-ATPase regulates the membrane dynamics remains to be elucidated.
We noted that endocrine cells might be a good system to explore V-ATPase function in regulated secretion: hormones to be secreted undergo sequential post-translational modifications that are thought to be dependent on luminal acidification, and vesicle fusion or hormone release are triggered by external or internal stimuli. In this study, we focused on the insulincontaining secretory granules in pancreatic ␤-cells. Previous studies suggested that the V-ATPase function might be important for the appropriate processing and maturation of insulin (Hutton, 1994; Orci et al., 1994; Orci et al., 1986; Smeekens et al., 1992) . However, a mutant mouse with defective V-ATPase subunits in their secretory vesicles could produce the mature active insulin, whereas the mutant was less competent for hormone secretion following stimulation both in vivo and in vitro. These results indicate that the a3 isoform of V-ATPase has a regulatory role in the secretion of insulincontaining granules.
Results

Expression and localization of a subunit isoforms in mouse pancreas
The V-ATPases in mammals, nematodes and flies exhibit structural and functional diversities as most of their subunits are not coded by a single gene but instead by multiple genes with distinctive structure. For the V O membrane-intrinsic sector, only single genes for the small, highly hydrophobic 16 kDa and 23 kDa subunits are functional in mammals (Hayami et al., 2001; Sun-Wada et al., 2001; Sun-Wada et al., 2000) . The a subunit is a protein with a relative molecular mass of approximately 100 kDa, with an N-terminal cytosolic portion and 9 membrane-spanning segments Nelson and Harvey, 1999; Nishi and Forgac, 2002; Sun-Wada et al., 2003) . In mammalian cells, four isoforms of the a subunit (a1, a2, a3 and a4) have been identified (Nishi and Forgac, 2000; Oka et al., 2001; Smith et al., 2001; Toyomura et al., 2000) . We have previously shown that the a1, a2 and a3 isoforms are expressed ubiquitously in mouse tissues (Toyomura et al., 2000) and exhibit distinct cellular localizations (Toyomura et al., 2003) . The a4 isoforms is unique, as its expression is restricted to kidney (Oka et al., 2001; Smith et al., 2001) .
In these studies, we noted that the pancreas accumulates significant amounts of mRNA of the a3 isoform, as well as the a3 isoform itself. We examined the distribution of the a1, a2 and a3 isoforms in mouse pancreas using isoform-specific antibodies (Toyomura et al., 2000) (Fig. 1A-D) . A strong signal of the a3 isoform was detected in almost all the cells in the islets of Langerhans (Fig. 1D) . The a3 isoform accumulated less in the surrounding pancreatic acini. The signals of a1 and a2 in the islet region were similar to signals in the surrounding tissues (Fig. 1B,C) . The insulin-secreting ␤-cells make up about 70% of the islet, whereas the glucagon-secreting ␣-cells constitute some 20% of the islet and tend to be distributed towards the periphery (Fig. 2) . Immunostaining of serial sections of the islet with anti-a3, anti-insulin and anti-glucagon antibodies revealed that the a3 isoform exhibited high expression in almost all the islet cells, including ␤, ␣ and other islet cells (Fig. 2) .
Next, we analyzed the cellular localization of a3 in two ␤-
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cell lines, ␤TC6 (Poitout et al., 1995) and ␤HC9 (Noda et al., 1996; Radvanyi et al., 1993) , which were established from genetically modified mice transgenic for SV40 large T antigen (Noda et al., 1996; Poitout et al., 1995; Radvanyi et al., 1993) . These cell lines preserve some distinctive characteristics of ␤-cells, including glucose-inducible insulin secretion, and thus provide a model system for dissecting the molecular mechanisms of regulated secretion (Noda et al., 1996; Poitout et al., 1995; Radvanyi et al., 1993) . In ␤TC6 cells, the a3 signal nearly completely overlapped that of insulin (Fig. 3A) , suggesting that a3 is localized to secretory granules containing insulin. Another class of secretory vesicles called synaptic-like microvesicles (SLMVs) in ␤-cells accumulate ␥-amino butyric acid (GABA), but not insulin (Moriyama et al., 1996) . SLMVs are stained by synaptophysin (Hayashi et al., 1998) as shown in Fig. 3 . However, the synaptophysin-positive compartments did not possess the a3 isoform, suggesting that the a3 isoform is preferentially localized to the insulin-containing secretory vesicles. The a3 signals did not overlap with those of other organelle marker proteins, including lysosome-associated membrane protein 2 (lamp-2; in lysosomes and late endosomes) Uthayakumar et al., 1990) and GM130 (in cis-Golgi) (Nakamura et al., 1997) (Fig. 3) . It is noteworthy that the a3 isoform is a resident of lysosomes and late endosomes in fibroblastic NIH3T3 cells or undifferentiated RAW 264.7 cells (Toyomura et al., 2003) . Similar results were obtained with ␤HC9 cells (Fig. 3B) . We found that the a3 isoform signal exhibited good merging with that of insulin, whereas a1 and a2 showed different localizations in ␤HC9 cells. We further assessed localization of the a3 isoform using immunoelectron microscopy. A substantial amount of the antia3 labeling was associated with vesicles containing electrondense cores, which is typical morphology of insulin-containing secretory granules (Fig. 4A ). The a3 labeling was found on the limiting membranes of the vesicles. We quantified the labeling by counting gold particles and found that over 80% of total gold particles were distributed in the vesicles with a dense core, whereas fewer than 5% of the particles were found in Golgi and late endosome/lysosomes (multi-vesicular bodies) (Fig. 4B) . From these immunohistological observations at tissue and ultra-structural levels, we concluded that the a3 isoform is expressed in mouse ␤-cells, and is preferentially localized in secretory vesicles containing insulin.
Expression of a3 in pancreatic islets of oc/oc mutant mice Osteosclerosis (oc) is an autosomal recessive mutation that impairs bone resorption by osteoclasts and induces a general increase in bone density in affected mice (Schlager and Dickie, 1967; Scimeca et al., 2000) . oc/oc homozygous mice survive for 4 weeks after birth, but begin to die around the weaning period. The oc mutation comprises a 1.6 kb deletion in the a3 subunit locus, which is involved in translation initiation (Scimeca et al., 2000) . Loss of the a3 subunit results in a lack of V-ATPase in the membranes of osteoclast cells, thereby preventing bone resorption (Scimeca et al., 2000) . Considering the large amount of accumulation of the a3 isoform in the insulin-containing granules, we expected that oc/oc mutants might develop metabolic disorders owing to endocrine dysfunction, although little has been described on pancreatic function in oc/oc mice. We examined protein levels of the V-ATPase a3 isoform by immunoblotting pancreas lysates using specific antibodies. The a3 isoform was not present in oc/oc pancreatic lysates, as expected from the fact that the mutation deletes the translation initiation codon and its surrounding region; thus, oc probably represents a null mutation. The a1 and a2 isoforms were present, as shown in Fig. 5 . Interestingly, the level of a2 was slightly elevated in the mutant mice compared with in the wild-type mice, suggesting that some compensating mechanisms might exist to maintain the cellular amounts of the V-ATPase complex. The slight elevation of the a2 isoform in the oc/oc mutant was also confirmed using total lysates prepared from pancreatic islets (Fig.  5B ). The localization of the a2 isoform in oc/oc ␤-cells was further examined by immunofluorescence staining. We found that the a2 signals were diffused and overlapped with that of insulin; whereas, the a2 signals were more concentrated in the perinuclear region in wild-type cells (Fig. 5C ). The morphology of the islets and the immunostaining intensity of insulin in the mutant mice were indistinguishable from those in the wild-type mice (Fig. 6A ). Although reduction of islet size is often associated with islet cell abnormalities (Unno et al., 2002) , no reduced ␤-cell mass was observed in oc/oc mice, indicating that differentiation/proliferation of ␤-cells was not affected by the loss of the a3 isoform. The lack of expression of the a3 isoform in oc/oc islets was also confirmed using serial sections (Fig. 6A , lower panels). The morphology of the secretory granules was examined using electron microscopy. Secretory vesicles with a dense core were observed both in oc/oc and wild-type islets (Fig. 6B ). We also measured the density of the secretory vesicles. There was no significant difference observed in the density of wild-type [148.5±8.9 (arbitrary unit), n=60] and oc/oc insulin granules (147.1±10.2, n=73, P>0.3, compared with wild-type granules).
Processing of insulin in the islets of oc/oc mice
Because the conversion of proinsulin to insulin is strictly dependent on a low pH (Orci et al., 1994; Smeekens et al., 1992) , we presumed that loss of the V-ATPase a3 isoform would result in abnormal luminal acidification, and thereby affect insulin processing and maturation. Insulin processing was examined using immunoblotting analysis of isolated islets. The insulin migrated to 3.5 kDa (separated A and B chains on a reducing gel) close to the position of human insulin in both the wild-type and oc/oc mice (Fig. 7, lanes 1, 2 and 3, arrows) . The anti-insulin antibody, which recognizes proinsulin as well, detected the 7.6 kDa proinsulin form in both the normal and mutant islets (Fig. 7, lanes 2 and 3, arrows) . The amounts of insulin and proinsulin decreased in the islets of oc/oc mice, consistent with the results of insulin content in islets determined by enzyme-linked immunosorbent assay (ELISA). Imunoblotting with anti-C-peptide also revealed the 7.6 kDa protein in both the wild-type and oc/oc mice (Fig. 7 , lanes 4 and 5, arrows). The ratios of the level of insulin over proinsulin were 1.74 and 1.63 for wild-type and mutant mice, respectively (Fig. 7) . The results indicated that proinsulin was converted to insulin in oc/oc mice, and no significant accumulation of proinsulin was found in the mutant mice. Furthermore, the lysates of wild-type and oc/oc pancreas evoked translocation of the GLUT-4 glucose transporter from intracellular compartments to the plasma membrane with almost similar dose responses; thus, the lysates of the mutant pancreas contained a biologically active form of insulin (data not shown). These observations indicated that the processing and maturation of insulin was not compromised even in the absence of the V-ATPase a3 subunit isoform, a major proton pump on the insulin-containing secretory granules.
Abnormal plasma insulin level in oc/oc mice Blood samples were collected from fasting and non-fasting mutant mice, and the blood insulin contents and glucose level were measured (Fig. 8A-C) . The plasma insulin level in natural-feeding oc/oc mice was lower than those in wild-type or heterozygous (oc/+) mice (Fig. 8A) . Oral glucose administration raised the blood glucose levels in both wild-type, oc/+ and oc/oc mice (Fig. 8C) , however, no changes in insulin level were found in oc/oc mutant mice, whereas the blood insulin level in wild-type and oc/+ mice increased (Fig. 8B ). These findings indicated that oc/oc mutant mice were defective in regulating the blood insulin level in response to an increase in the blood glucose level.
Insulin secretion from isolated islets oc/oc mutant mice could produce mature active insulin in pancreatic ␤-cells but failed to raise the blood insulin level after glucose intake. This phenotype might reflect defective insulin secretion in response to glucose loading in oc/oc pancreatic ␤-cells. We prepared islets from wild-type and oc/oc mice, and measured their secretion activities in the response to glucose or depolarization stimulus. At basal conditions (in the presence of 2.8 mM glucose and 5 mM KCl), insulin secretion of oc/oc islets was slightly low (Fig. 9A) . We found that the insulin content per islet protein in oc/oc mice was approximately half of that of wild-type mice (Fig.  9B) ; this reduction might reflect the lower insulin secretion at the basal level. In the presence of 16.7 mM glucose or 60 mM KCl, insulin secretion from the oc/oc islets was significantly lower than those of the wild-type islets (Fig. 9A) , indicating that the mutant islets did not effectively respond to the stimulus and were practically defective in insulin secretion. The localization of the a3 subunit did not colocalize with GABA vesicles, which contain synaptophysin as a marker. We have also examined GABA secretion using isolated islets, and no significant difference was observed between wild-type and oc/oc pancreatic islets (data not shown). Therefore, the secretion defect was specific for insulin.
Granule acidification and insulin secretion
We found that the secretory granules of oc/oc mutant ␤-cells were still stained with an acidotropic reagent, LysoTracker, suggesting that the secretory granules without the a3 isoform were acidified to a certain degree (Fig. 10A) . It is interesting to know whether insulin secretion is dependent on V-ATPase pump activity or on the physical presence of the VATPase. We treated ␤HC9 cells with bafilomycin A, Journal of Cell Science 119 (21) Fig. 3 . Localization of the a3 isoform to secretory granules in ␤TC6 and ␤HC9 cells. (A) ␤TC6 cells grown on a slide glass were stained with antibodies against the a3 isoform (green), and insulin, lamp-2, GM130, or synaptophysin (red). (B) ␤HC9 cells were stained with antibodies against the a isoforms (a1, a2 and a3, green) and insulin, lamp-2, GM130, or synaptophysin (red). Merged images are also shown. Bar, 10 m. a specific inhibitor of V-ATPase, and measured the insulin secretion. The acidification of the secretory granules was monitored by LysoTracker staining. We found that the LysoTracker staining was almost absent after treatment with bafilomycin (10 nM) for 1 hour (Fig. 10B ), yet the secretion of insulin was not significantly affected (Fig.  10C) . These results suggest that the acidification itself is not directly involved in the secretion of existing secretory granules.
Discussion
The a3 isoform of V-ATPase is targeted to the membranes of secretory granules V-ATPases are the most prominent proton pumps functioning in both intracellular and extracellular acidification. They are indispensable for many cellular functions, including receptormediated endocytosis, protein processing and degradation. This complex proton pump also generates the proton motive forces across the organelle membranes that are in turn utilized as driving forces for numerous secondary transport processes (Nelson and Harvey, 1999; Stevens and Forgac, 1997; SunWada et al., 2003) . The genetic loss of a common subunit of V-ATPase (the 16 kDa proteolipid) in mice results in growth arrest and defects in organelle morphology in the periimplantation stage of embryo development, indicating that VATPase plays an essential role in mammalian cells. The proteolipid is encoded by a single gene in both humans and mice; thus, since all V-ATPase complexes in a variety of tissues and cells possess this subunit, its genomic disruption results in the loss of function of V-ATPases in whole animals . Other subunits, including the large 100 kDa a subunit, are encoded by multiple genes, and the diverse intracellular localization of V-ATPase is achieved in part by expressing these distinct isoforms of the membraneintegral a subunit (Kawasaki- Nishi et al., 2001; Toyomura et al., 2003) .
In this study, we found that one of the a isoforms, a3, is localized to the membranes of insulin-containing secretory granules in pancreatic ␤-cells, whereas the other subunit isoforms, a1 and a2, are localized to the compartments negative for insulin. Therefore, the a3 isoform of V-ATPase is specifically targeted to the insulin-containing secretory granules in ␤-cells. In undifferentiated cells, the a3 isoform localizes to late endosomes and lysosomes (Toyomura et al., 2003) , and participates in the acidification of these lytic compartments. During differentiation of osteoclasts, which have the a3 isoform of V-ATPase on the plasma membrane, the V-ATPase and the lysosomal protein lamp-2 are recruited to the plasma membrane together. In ␤-cells, a3 and lamp-2 are not precisely colocalized within the intracellular compartments. Therefore, the sorting mechanisms for lamp-2 and a3 are not the same under different cellular contexts (i.e. differentiating osteoclasts and pancreatic ␤-cells), and the intracellular sorting events for the V-ATPase isoforms seem to be more complicated than we discussed previously (Toyomura et al., 2003) .
Processing of insulin and secretory granule acidification
It has been shown that proinsulin is converted to insulin through the actions of two endopeptidases whose activities are dependent on an acidic pH and the presence of Ca 2+ (Orci et Journal of Cell Science 119 (21) al., 1986). The conversion is inhibited by ionophores, which disrupt the intracellular proton gradient (Orci et al., 1986) , demonstrating that an acidic environment is necessary for the enzyme reaction in vivo. These results lead us to presume that V-ATPase with the a3 isoform might be involved in the conversion of insulin. It was unexpected to find out that the a3 isoform or a3-mediated acidification is not an absolute requirement for insulin processing. From the immunoblotting analysis and morphology of the dense-core granules observed by electron microscopy, we found that the maturation of insulin was normal in the islets of oc/oc mutant mice lacking the a3 isoform. In addition, insulin extracted from the oc/oc mutant mice had the potential to evoke GLUT-4 translocation in 3T3L1 adipocytes, indicating that this insulin is indistinguishable from that produced in the wild-type mouse in terms of its activities (G.-H.S.-W., unpublished data). The primary site of the conversion, revealed by previous immunoelectron microscopy studies, is clathrin-coated vesicles, which are less acidic than mature secretory granules and more proximal to the Golgi apparatus (Orci et al., 1986; Orci et al., 1987) , where the a2 isoform is the major constituent for V-ATPase (Toyomura et al., 2003) . It is possible that the processing of insulin is carried out in some compartments that are acidified by V-ATPase with other a isoforms (e.g. the a2 isoform). The expression level of the a2 isoform was elevated in the homozygous oc mutant (Fig. 5) . The localization of a2 in mutant ␤-cells overlapped partially with that of insulin, whereas this ovelapping was not observed in wild-type cells. This upregulation could also be a reason why oc/oc mutant mice do not develop severe defects in insulin maturation. In addition, we found that the secretory granules of oc/oc mutant ␤-cells were still stained with an acidotropic reagent, LysoTracker, suggesting that the secretory granules without the a3 isoform were acidified to a certain degree. It is possible that the acidification of secretory granules could be compensated by the a2 subunit isoform.
The a subunit isoform has a regulatory role in secretion Recently, several lines of studies have reported the requirement of the V-ATPase V O subunit a isoform for exocytosis. The V O complex has been shown to be required for membrane fusion downstream of SNARE action in a yeast vacuolar fusion (Bayer et al., 2003; Peters et al., 2001) . The a1 subunit isoform in Drosophila has been demonstrated to interact with SNARE proteins and function as a regulator of synaptic vesicle fusion efficiency downstream of SNARE-dependent vesicle priming (Hiesinger et al., 2005) . Our results showed that the mutant mice without the a3 isoform exhibited a significantly lower level of plasma insulin than the wild-type mice, despite the fact they produced and contained substantial amounts of insulin in the pancreas. Insulin secretion in response to glucose or depolarizing stimulation was significantly impaired in oc/oc mutant islets. The defects in secretion could be explained, at least in part, by the decrease in insulin content in islets, which was also reduced in the oc/oc mice. However, the decrease in insulin secretion (~75%) was even lower than the insulin content. These observations suggest that the mutants are defective in the step of exocytosis of secretory granules. Analysis of the effect of bafilomycin treatment on insulin secretion using ␤HC9 cells supported the idea that insulin secretion might be dependent on the physical presence of the V-ATPase subunit.
The blood glucose levels of oc/oc mutants were not significantly affected, although the insulin levels were low. In addition, oc/oc mice do not develop any apparent sign of hyperglycemia as shown in Fig. 8C . As shown in Figs 2 and 3, the a3 isoform was also expressed in glucagon-secreting cells. We have also measured the secretion of glucagons from isolated islets and found that their secretion from mutant islets was also impaired (G.-H.S.-W., M.F. and Y.W., unpublished data). Requirement of a3 function in glucagon secretion might be an explanation for the lack of apparent hyperglycemia. The expression of the a3 isoform is not restricted to the pancreas or osteoclasts, thus the oc mutation affects many other cellular and tissue functions in the whole animal. Indeed, we and others noted that the oc/oc mutation affects animal physiology severely, and the mutant animals exhibit growth retardation (Li et al., 1999; Scimeca et al., 2000; Steward, 2003) and abnormal behavior (our unpublished observation), and cannot survive more than a month after birth. We found that the a3 isoform is strongly expressed in secretory cells in various organs, including the adrenal gland, parathyroid gland, pituitary gland and pineal gland (G.-H.S.-W., M.F. and Y.W., unpublished data), which all have essential endocrine functions to maintain whole animal homeostasis. The apparent discrepancy in the blood insulin and glucose levels in oc/oc mutants might be reflecting deregulated endocrine homeostasis. In addition, the mutants and their normal littermates are highly likely to take different qualities and quantities of diet (normal chew or mother milk, etc.) because oc/oc mutants are defective in tooth development, which takes place around two weeks after birth (Li et al., 1999) in the normal littermates. The mutant mice could be distinguished easily from the heterozygous or wildtype littermates at a glance by their small sizes and their lack of incisor eruption. Their blood glucose levels reflect these differences in gross physiological parameters.
Several lines of studies for human insulin-dependent (type 1) diabetes mellitus (IDDM) have identified susceptibility regions on human chromosomes. The human V-ATPase a3 isoform, encoded by the ATP6i gene, was mapped to chromosome 11q13, a region that has been linked to IDDM4 (Davies et al., 1994; Hashimoto et al., 1994) . Several positional candidates including FADD, GALN (Eckenrode et al., 2000) and LRP5 (Twells et al., 2003) have been investigated, although the functional candidate gene has not been identified yet. The ATP6i gene, also designated as TCIRG1, is located approximately 200 kb apart from the LRP5 locus, which shows strong linkage to the disease (Twells et al., 2003) . Our results raise the possibility that genetic alteration(s) of the gene encoding human a3 could also contribute to IDDM.
Materials and Methods
Materials and animals
Antibodies against subunit a isoforms were prepared as described previously (Toyomura et al., 2003; Toyomura et al., 2000) . Polyclonal anti-A antibodies (WAKO), and monoclonal antibodies for lamp-2 (rat clone GL2A7; DSHB), actin (mouse AC-15; Abcam), and GM130 (mouse clone 35; Harlan Sera-Lab) were used in the experiments. The anti-insulin and C-peptide antibodies were obtained from DAKO and Linco, respectively. Other materials were also from commercial sources: fluorescein isothiocyanate (FITC)-and Cy3-conjugated secondary antibodies were from Jackson ImmunoResearch; Dulbecco's modified Eagle medium (DMEM), minimal essential medium (MEM) and fetal bovine serum (FBS) were from Invitrogen; and recombinant mouse insulin was from Seikagaku Kogyo.
C57Bl/6J-C3H/FeJ F1 oc/+ mice were obtained from the Jackson Laboratory (Schlager and Dickie, 1967; Scimeca et al., 2000) . Heterozygous oc/+ mice were identified by genotyping analysis and homozygous oc/oc mice were obtained through heterozygous mating. C57Bl/6J mice were purchased from SLC Japan. All animal experiments were carried out in accordance with institutional policies.
Genotyping
Tail DNA prepared by phenol-chloroform extraction was subjected to semi-nested PCR. The wild-type allele was detected as a 2.3 kb product using primers OC-Fw (5Ј-TATAGTAAGTGGACTGT-3Ј) and OC-Rv (5Ј-CTCATTCCATGGGATGTGA-ATCTG-3Ј). The oc allele was detected as a 0.52 kb product with primers OC-mid (5Ј-ATCATGGGCTCTATGTTCCGGAGT-3Ј) and OC-Rv.
Western blot analysis
A mouse pancreas was dissected at 4°C. Lysate preparation and immunoblotting procedures were performed as previously described (Sun-Wada et al., 2002) . For analysis of insulin processing, the islet total lysates were applied at 5 g/lane on 15-25% gradient polyacrylamide gel (Daiich Pure Chemicals) and transferred to PVDF membrane with 0.2 m pore size. The immunoblots were performed with anti-insulin and c-peptide antibodies. The protein blot was developed with an ECL detection kit (GE Healthcare), and images were obtained using an image capture system (model LAS1000; Fujifilm). The intensities of bands were measured and analyzed using Image Gauge Software (Fujifilm).
Cell culture ␤HC9 cells (Noda et al., 1996; Radvanyi et al., 1993) , a kind gift from D. Hanahan (University of California, San Francisco, CA), were grown in DMEM containing 15% horse serum, 2.5% FBS, 1 mM pyruvate and 25 mM glucose. ␤TC6 cells (Poitout et al., 1995) were grown in DMEM containing 15% FBS, 4 mM glutamate and 25 mM glucose, and maintained at 37°C under 5% CO 2 .
Immunohistochemistry
The immunnofluorescence of cultured cells were performed as previously described (Toyomura et al., 2003) . Fluorescence images were acquired with a confocal microscope, LSM 510 (Carl Zeiss). To stain the islets of Langerhans, mice (C57Bl/6J male; 6 weeks old) were anesthetized and then perfused with 4% paraformaldehyde in phosphate-buffered saline (PBS) (pH 7.4). Each pancreas was dissected out, and then successively infiltrated with 30% sucrose in PBS, embedded in OCT compound (Miles), and stored frozen. Sections of 6 m thickness were mounted on gelatin-coated slides, and then stained with hematoxylin. Sections were stained immunochemically as described previously (Sun-Wada et al., 2002) .
Oral glucose administration and insulin measurement
Mice (oc/oc, oc/+ and +/+; 3 weeks old) were fasted for 4 hours and were then administered glucose through a stomach tube (1.5 mg/g body wt intragastrical administration). Blood was collected in heparinized tubes 10 minutes after glucose administration. Blood glucose was measured using an automatic blood glucose meter (Glutest Ace; Sanea Chemicals). Insulin levels were measured with an enzyme-linked immunosorbent assay (ELISA) kit (Morinaga or Shibayagi) using a mouse insulin standard (Seikagaku Kogyo).
Islet isolation and in vitro secretion assay
Islets were isolated as previously described (Kasai et al., 2005; Wang et al., 1999) with several modifications. Briefly, the pancreas was dissected from 3-week-old mice, digested in 500 U/ml of collagenase solution (Type XI; Sigma-Aldrich) for 30 minutes at 37°C with shaking several times during incubation. Islets were picked up by hand selection under a dissecting microscope and cultured overnight in RPMI1640 (11 mM glucose) supplemented with 10% fetal calf serum, 100 units/ml penicillin and 100 g/ml streptomycin. Then, 10 islets were transferred into a microfuge tube and incubated for 30 minutes in modified Krebs-Ringer buffer (Kasai et al., 2005) [120 mM NaCl, 5 mM KCl, 24 mM NaHCO 3 , 1 mM MaCl 2 , 2 mM CaCl 2 , 15 mM HEPES (pH 7.4) and 0.1% BSA]. The islets were then incubated at the same buffer for 30 minutes, followed by 30 minutes in the buffer containing secretagogues (16.7 mM glucose or 60 mM KCl). At the time of each medium change, the islets were sedimented by centrifuged at 700 g for 5 minutes, and media were collected and again centrifuged for 5 minutes to remove any cell debris. Immunoreactive insulin was measured using ELISA (Shibayagi). For ␥-aminobutyric acid (GABA) assay, isolated islets were precultured overnight in RPMI1640 (11 mM glucose) supplemented with 10% fetal calf serum, 100 units/ml penicillin and 100 g/ml streptomycin. Then, 30 islets were cultured for 15 hours in Ham's F-10 medium (Invitrogen) supplemented with 2 mM glutamine, 6.1 mM glucose, 0.2% (wt/vol) charchol-extracted BSA (Type V; Sigma). GABA in the cultured media was measured by HPLC (Smolders et al., 1995) .
For bafilomycin A inhibitory experiments, the ␤HC9 cells were cultured in 12-well plates in DMEM. Each well was washed with 1 ml of PBS and then incubated in DMEM with or without 10 nM bafilomycin at 37°C for 1 hour. Glucose was then added to each well to a final concentration of 25 mM. The medium was collected, centrifuged at 3500 g for 2 minutes, and the supernatant was collected and stored at -20°C until ELISA assay for insulin. The bafilomycintreated or control cells were stained with LysoTracker (Molecular Probes) for 15 minutes, and fixed with with 4% paraformaldehyde in PBS (pH 7.4). Fluorescence images were acquired with a confocal microscope, LSM 510 (Carl Zeiss).
Total insulin content
The islet was extracted in an acid-ethanol solution (70% ethanol and 0.18 M HCl) and then sonicated for 20 seconds. The immunoreactive insulin in the supernatant was measured using ELISA (Shibayagi). The acid-ethanol extraction was precipitated with 10% trichloroacetic acid (TCA) (final concentration of TCA was 5%) and the total protein concentration was measured using the BCA Protein Assay (Pierce).
Conventional and immunogold electron microscopy
Conventional electron microscopy was performed as previously described (SunWada et al., 2000) . Ultra-thin sections were doubly stained with uranylacetate and lead citrate, and then observed under a Hitachi H7000 electron microscope. The densities of secretory granules were measured and analyzed using Image Gauge software (Fujifilm). For immunoelectron microscopy, the pre-embedded silver enhancement immunogold method was used (Nakamura et al., 2000) . A pancreas was fixed in 4% paraformaldehyde in PBS overnight at 4°C. Cryo-sections (6 m) were incubated with the primary antibodies overnight, followed by incubation with the secondary antibodies conjugated with colloidal gold (1.4 nm diameter). The gold labeling was intensified using a silver enhancement kit (Nano Probes). The quantification of the gold particle distribution was performed in representative sections of a number of cells (n=6). 
